company background image
PSYG logo

Psyence Group CNSX:PSYG Stock Report

Last Price

CA$0.035

Market Cap

CA$7.0m

7D

-30.0%

1Y

-73.1%

Updated

27 Mar, 2024

Data

Company Financials

PSYG Stock Overview

Psyence Group Inc., a life science biotechnology company, engages in the commercial psilocybin mushroom cultivation and production activities.

PSYG fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Psyence Group Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Psyence Group
Historical stock prices
Current Share PriceCA$0.035
52 Week HighCA$0.17
52 Week LowCA$0.015
Beta0.21
1 Month Change16.67%
3 Month Change-22.22%
1 Year Change-73.08%
3 Year Change-90.00%
5 Year Changen/a
Change since IPO-93.64%

Recent News & Updates

Recent updates

Shareholder Returns

PSYGCA BiotechsCA Market
7D-30.0%-1.8%0.2%
1Y-73.1%-28.6%9.0%

Return vs Industry: PSYG underperformed the Canadian Biotechs industry which returned -28.6% over the past year.

Return vs Market: PSYG underperformed the Canadian Market which returned 9% over the past year.

Price Volatility

Is PSYG's price volatile compared to industry and market?
PSYG volatility
PSYG Average Weekly Movement43.5%
Biotechs Industry Average Movement13.5%
Market Average Movement8.6%
10% most volatile stocks in CA Market18.5%
10% least volatile stocks in CA Market3.1%

Stable Share Price: PSYG's share price has been volatile over the past 3 months.

Volatility Over Time: PSYG's weekly volatility (43%) has been stable over the past year, but is still higher than 75% of Canadian stocks.

About the Company

FoundedEmployeesCEOWebsite
2019n/an/ahttps://www.psyence.com

Psyence Group Inc., a life science biotechnology company, engages in the commercial psilocybin mushroom cultivation and production activities. Its natural psilocybin is used for the treatment of a range of mental health disorders and other medical conditions. The company is developing pharmaceutical preparations of psilocybin doses to help heal psychological trauma and diagnosable disorders, including anxiety, depression, post-traumatic stress disorder, and grief and bereavement.

Psyence Group Inc. Fundamentals Summary

How do Psyence Group's earnings and revenue compare to its market cap?
PSYG fundamental statistics
Market capCA$6.96m
Earnings (TTM)-CA$5.13m
Revenue (TTM)n/a

0.0x

P/S Ratio

-0.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PSYG income statement (TTM)
RevenueCA$0
Cost of RevenueCA$0
Gross ProfitCA$0
Other ExpensesCA$5.13m
Earnings-CA$5.13m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.037
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0%

How did PSYG perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.